There is growing evidence supporting the effectiveness of GLP-1 receptor agonists (GLP-1 RAs) for weight management ( 1 3 ), including some of our own Truveta research
Glucagon-like peptide 1 (GLP-1) agonists are a class of drugs that are approved by the FDA for weight loss in obese people without diabetes or to treat type 2 diabetes
But they like not only being big, but getting bigger
Successful clinical trials and approval for these GLP-1 drugs led to an increase in GLP-1RAs, but once-daily use was still a barrier for some patients with diabetes or obesity because of the frequent use of needles for daily injections
About three-quarters of users in each group 77% of those taking compounded or custom-mixed medications and 74% of those taking brand-name drugs said the treatments are either "effective" or "extremely effective." Compounded GLP-1 users were slightly more likely to rate the medications as "extremely effective," with 39% reporting that level of effectiveness compared with 32% of brand-name medication users
Some need help controlling cravings, while others struggle with emotional or stress-related eating